72 related articles for article (PubMed ID: 10864476)
1. Interaction of angiogenesis inhibitor TNP-470 with basic fibroblast growth factor receptors.
Bond SJ; Klein SA; Anderson GL; Wittliff JL
J Surg Res; 2000 Jul; 92(1):18-22. PubMed ID: 10864476
[TBL] [Abstract][Full Text] [Related]
2. Angiogenesis inhibitor TNP-470 inhibits murine cutaneous wound healing.
Klein SA; Bond SJ; Gupta SC; Yacoub OA; Anderson GL
J Surg Res; 1999 Apr; 82(2):268-74. PubMed ID: 10090839
[TBL] [Abstract][Full Text] [Related]
3. Acidic and basic fibroblast growth factor bind with differing affinity to the same heparan sulfate proteoglycan on BALB/c 3T3 cells: implications for potentiation of growth factor action by heparin.
Brown KJ; Hendry IA; Parish CR
J Cell Biochem; 1995 May; 58(1):6-14. PubMed ID: 7543903
[TBL] [Abstract][Full Text] [Related]
4. Heparan sulfate primed on beta-D-xylosides restores binding of basic fibroblast growth factor.
Miao HQ; Fritz TA; Esko JD; Zimmermann J; Yayon A; Vlodavsky I
J Cell Biochem; 1995 Feb; 57(2):173-84. PubMed ID: 7759555
[TBL] [Abstract][Full Text] [Related]
5. Basic fibroblast growth factor (bFGF) receptors decrease with luteal age in rat ovarian luteal cells: colocalization of bFGF receptors and bFGF in luteal cells.
Asakai R; Tamura K; Eishi Y; Iwamoto M; Kato Y; Okamoto R
Endocrinology; 1993 Sep; 133(3):1074-84. PubMed ID: 7689947
[TBL] [Abstract][Full Text] [Related]
6. In vivo chamber angiogenesis assay: an optimized Matrigel plug assay for fast assessment of anti-angiogenic activity.
Kragh M; Hjarnaa PJ; Bramm E; Kristjansen PE; Rygaard J; Binderup L
Int J Oncol; 2003 Feb; 22(2):305-11. PubMed ID: 12527927
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of TNP-470 on experimental choroidal neovascularization in a rat model.
Ishida K; Yoshimura N; Mandai M; Honda Y
Invest Ophthalmol Vis Sci; 1999 Jun; 40(7):1512-9. PubMed ID: 10359334
[TBL] [Abstract][Full Text] [Related]
8. The accelerating effect of histamine on the cutaneous wound-healing process through the action of basic fibroblast growth factor.
Numata Y; Terui T; Okuyama R; Hirasawa N; Sugiura Y; Miyoshi I; Watanabe T; Kuramasu A; Tagami H; Ohtsu H
J Invest Dermatol; 2006 Jun; 126(6):1403-9. PubMed ID: 16543894
[TBL] [Abstract][Full Text] [Related]
9. Quantitative characterization of high- and low-affinity binding sites for basic fibroblast growth factor on trabecular cells of the eye.
Tripathi RC; Borisuth NS; Li J; Tripathi AJ; Tripathi BJ
Exp Eye Res; 1997 Mar; 64(3):335-41. PubMed ID: 9196384
[TBL] [Abstract][Full Text] [Related]
10. Heparan sulfate proteoglycans control intracellular processing of bFGF in vascular smooth muscle cells.
Sperinde GV; Nugent MA
Biochemistry; 1998 Sep; 37(38):13153-64. PubMed ID: 9748322
[TBL] [Abstract][Full Text] [Related]
11. Interaction of basic fibroblast growth factor with bovine growth plate chondrocytes.
Trippel SB; Whelan MC; Klagsbrun M; Doctrow SR
J Orthop Res; 1992 Sep; 10(5):638-46. PubMed ID: 1323648
[TBL] [Abstract][Full Text] [Related]
12. Laminarin sulfate mimics the effects of heparin on smooth muscle cell proliferation and basic fibroblast growth factor-receptor binding and mitogenic activity.
Miao HQ; Ishai-Michaeli R; Peretz T; Vlodavsky I
J Cell Physiol; 1995 Sep; 164(3):482-90. PubMed ID: 7650058
[TBL] [Abstract][Full Text] [Related]
13. Antiangiogenic drugs for chemotherapy of bladder tumours.
Rocchetti R; Talevi S; Margiotta C; Calza R; Corallini A; Possati L
Chemotherapy; 2005 Oct; 51(6):291-9. PubMed ID: 16224178
[TBL] [Abstract][Full Text] [Related]
14. Internalization of basic fibroblast growth factor (bFGF) in cultured endothelial cells: role of the low affinity heparin-like bFGF receptors.
Rusnati M; Urbinati C; Presta M
J Cell Physiol; 1993 Jan; 154(1):152-61. PubMed ID: 8419401
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of the angiogenesis inhibitor TNP-470 in reducing the growth of human neuroblastoma in nude mice inversely correlates with tumor burden.
Katzenstein HM; Rademaker AW; Senger C; Salwen HR; Nguyen NN; Thorner PS; Litsas L; Cohn SL
Clin Cancer Res; 1999 Dec; 5(12):4273-8. PubMed ID: 10632370
[TBL] [Abstract][Full Text] [Related]
16. TNP-470 reduces collagen and macrophage accumulation in expanded polytetrafluoroethylene tube implants.
Bond SJ; Klein SA
J Surg Res; 2001 Nov; 101(1):99-103. PubMed ID: 11676562
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of binding of basic fibroblast growth factor to low and high affinity receptors by carrageenans.
Hoffman R; Sykes D
Biochem Pharmacol; 1993 Jun; 45(11):2348-51. PubMed ID: 8517877
[TBL] [Abstract][Full Text] [Related]
18. Topical treatment with basic fibroblast growth factor promotes wound healing and barrier recovery induced by skin abrasion.
Nakamizo S; Egawa G; Doi H; Natsuaki Y; Miyachi Y; Kabashima K
Skin Pharmacol Physiol; 2013; 26(1):22-9. PubMed ID: 23108135
[TBL] [Abstract][Full Text] [Related]
19. Basic fibroblast growth factor receptor in the rat adrenal cortex: effects of suramin and unilateral adrenalectomy on receptor numbers.
Basile DP; Holzwarth MA
Endocrinology; 1994 Jun; 134(6):2482-9. PubMed ID: 8194474
[TBL] [Abstract][Full Text] [Related]
20. TNP-470 and recombinant human interferon-alpha2a inhibit angiogenesis synergistically.
Minischetti M; Vacca A; Ribatti D; Iurlaro M; Ria R; Pellegrino A; Gasparini G; Dammacco AF
Br J Haematol; 2000 Jun; 109(4):829-37. PubMed ID: 10929037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
